Skip to main content

Pharmacokinetics in Healthy Subjects

1
Pipeline Programs
1
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allecra Therapeutics
Allecra TherapeuticsFrance - Saint Louis
1 program
1
cefepimePhase 15 trials
Active Trials
NCT05826990Unknown40Est. Mar 2026
NCT03687255Completed1,043Est. Feb 2020
NCT03680612Completed45Est. Feb 2018
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime

Clinical Trials (6)

Total enrollment: 1,233 patients across 6 trials

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Start: Sep 2018Est. completion: Feb 20201,043 patients
Phase 3Completed

A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI

Start: Sep 2023Est. completion: Mar 202640 patients
Phase 2Unknown

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Start: Sep 2017Est. completion: Feb 201845 patients
Phase 2Completed

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Start: Sep 2017Est. completion: Dec 201830 patients
Phase 1Completed

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Start: Jul 2017Est. completion: Apr 201919 patients
Phase 1Completed

Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers

Start: Oct 2013Est. completion: Jan 201456 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.